# Quebec Lung Cancer Screening PLUS Trial

> **NCT05444062** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Nicole Ezer, MD, FRCPC, MPH** · enrollment: 330 (estimated)

## Conditions studied

- COPD
- Coronary Artery Calcification

## Interventions

- **BEHAVIORAL:** Educational material and treatment recommendations for patients, general practitioners and pharmacists

## Key facts

- **NCT ID:** NCT05444062
- **Lead sponsor:** Nicole Ezer, MD, FRCPC, MPH
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-04-23
- **Primary completion:** 2026-02
- **Final completion:** 2027-09
- **Target enrollment:** 330 (ESTIMATED)
- **Last updated:** 2025-08-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05444062

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05444062, "Quebec Lung Cancer Screening PLUS Trial". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT05444062. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*